<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36417015</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI).</ArticleTitle><Pagination><StartPage>941</StartPage><EndPage>946</EndPage><MedlinePgn>941-946</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-06505-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aimed at providing diagnostic properties and normative cut-offs for the Italian ECAS Carer Interview (ECAS-CI).</AbstractText><AbstractText Label="MATERIALS" NlmCategory="METHODS">N&#x2009;=&#x2009;292 non-demented ALS patients and N&#x2009;=&#x2009;107 healthy controls (HCs) underwent the ECAS-CI and the Frontal Behavioural Inventory (FBI). Two ECAS-CI measures were addressed: (1) the number of symptoms (NoS; range&#x2009;=&#x2009;0-13) and (2) that of individual symptom clusters (SC; range&#x2009;=&#x2009;0-6). Diagnostics were explored against an FBI score&#x2009;&#x2265;&#x2009;than the 95th percentile of the patients' distribution.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both the NoS and SC discriminated patient from HCs. High accuracy, sensitivity, and specificity were detected for both the NoS and SC; however, at variance with SC, the NoS showed better post-test features and did not overestimate the occurrence of behavioural changes. The ECAS-CI converged with the FBI and diverged from the cognitive section of the ECAS.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The ECAS-CI is a suitable screener for behavioural changes in ALS patients, with the NoS being its best outcome measure (cut-off:&#x2009;&#x2265;&#x2009;3).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Poletti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4398-2051</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy. b.poletti@auxologico.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Aiello</LastName><ForeName>Edoardo Nicol&#xf2;</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solca</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrucci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, San Paolo University Hospital, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Behavioural symptom</Keyword><Keyword MajorTopicYN="N">Edinburgh Cognitive and Behavioural ALS Screen</Keyword><Keyword MajorTopicYN="N">Frontotemporal degeneration</Keyword><Keyword MajorTopicYN="N">Psychometrics</Keyword></KeywordList><CoiStatement>V.S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG, receives or has received research supports from the Italian Ministry of Health, AriSLA and E-Rare Joint Transnational Call. He is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i>. B.P. and L.C. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. N.T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for <i>Frontiers in Aging Neuroscience</i>.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36417015</ArticleId><ArticleId IdType="pmc">PMC9925466</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06505-x</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-06505-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9&#x2013;14. doi: 10.3109/21678421.2013.805784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, &#x2026; Turner MR (2017) Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria.Amyotroph Lateral Scler Frontotemporal Degener 18:153&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:1&#x2013;11. doi: 10.1080/21678421.2018.1530264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1530264</ArticleId><ArticleId IdType="pubmed">30585510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselt IK, Nijboer TC, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:324&#x2013;336. doi: 10.1080/21678421.2020.1732424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1732424</ArticleId><ArticleId IdType="pubmed">32157912</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Ahmed R, Mahoney CJ, Nguyen C, Tu S, Caga J, ... Kiernan MC (2020) The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.Expert Rev Neurother 20:281&#x2013;293</Citation><ArticleIdList><ArticleId IdType="pubmed">32031423</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, D&#x2019;Iorio A, Montemurro S, Maggi G, Giacobbe C, Bari V, ... Santangelo G (2022) Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review. Neurol Sci 43: 6189&#x2013;6214</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9616758</ArticleId><ArticleId IdType="pubmed">35932375</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, ... Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;2477</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, ... Grossman M (2011) Classification of primary progressive aphasia and its variants.Neurology 76:1006&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, &#x2026; Silani V (2016) The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS).Amyotroph Lateral Scler Frontotemporal Degener 17:489&#x2013;498</Citation><ArticleIdList><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberici A, Geroldi C, Cotelli M, Adorni A, Calabria M, Rossi G, &#x2026; Kertesz, A (2007) The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer&#x2019;s disease.Neurol Sci 28:80&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">17464470</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu AE. easyROC: an interactive web-tool for ROC curve analysis using R language environment. R J. 2016;8:213. doi: 10.32614/RJ-2016-042.</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2016-042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HY. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52&#x2013;54. doi: 10.5395/rde.2013.38.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.5395/rde.2013.38.1.52</ArticleId><ArticleId IdType="pmc">PMC3591587</ArticleId><ArticleId IdType="pubmed">23495371</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Depaoli EG, Gallucci M. Usability of the negative binomial model for analyzing ceiling and highly-inter-individually-variable cognitive data. Neurol Sci. 2020;41:S273&#x2013;S274.</Citation></Reference><Reference><Citation>Iazzolino B, Pain D, Laura P, Aiello EN, Gallucci M, Radici A, &#x2026; Chi&#xf2; A (2022) Italian adaptation of the Beaumont behavioral inventory (BBI): psychometric properties and clinical usability. Amyotroph Lateral Scler Frontotemporal Degener 23:81&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">34279169</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A, Abrahams S, Sorar&#xf9; G, Mattiuzzi L, D&#x2019;Ascenzo C, Pegoraro E, Angelini C. Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci. 2009;278:16&#x2013;20. doi: 10.1016/j.jns.2008.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.10.025</ArticleId><ArticleId IdType="pubmed">19103449</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G, Siciliano M, Trojano L, Femiano C, Monsurr&#xf2; MR, Tedeschi G, Trojsi F. Apathy in amyotrophic lateral sclerosis: insights from dimensional apathy scale. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:434&#x2013;442. doi: 10.1080/21678421.2017.1313865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313865</ArticleId><ArticleId IdType="pubmed">28431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, Monsurr&#xf2; MR, Tedeschi G, Santangelo G. Assessing anxiety and its correlates in amyotrophic lateral sclerosis: the state-trait anxiety inventory. Muscle Nerve. 2019;60:47&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">30897219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain D, Aiello EN, Gallucci M, Miglioretti M, Mora G. The Italian version of the ALS Depression Inventory-12. Front Neurol. 2021;12:723776. doi: 10.3389/fneur.2021.723776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.723776</ArticleId><ArticleId IdType="pmc">PMC8497880</ArticleId><ArticleId IdType="pubmed">34630298</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, ... Silani V (2018) Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS).Amyotroph Lateral Scler Frontotemporal Degener 19:387&#x2013;395</Citation><ArticleIdList><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Iazzolino B, Pain D, Peotta L, Palumbo F, Radici A, &#x2026; Chi&#xf2; A (2022) The diagnostic value of the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 23:527&#x2013;531</Citation><ArticleIdList><ArticleId IdType="pubmed">35311435</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Solca F, Torre S, Carelli L, Monti A, Ferrucci R, &#x2026; Poletti B (2022) Reliable change indices for the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 1&#x2013;5.&#xa0;10.1080/21678421.2022.2134801</Citation><ArticleIdList><ArticleId IdType="pubmed">36286187</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients&#x2019; behavioral changes than physical disability: a comparative study. BMC Neurol. 2012;12:1&#x2013;6. doi: 10.1186/1471-2377-12-156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-12-156</ArticleId><ArticleId IdType="pmc">PMC3541170</ArticleId><ArticleId IdType="pubmed">23216745</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>